AN2 Therapeutics Inc
NASDAQ:ANTX

Watchlist Manager
AN2 Therapeutics Inc Logo
AN2 Therapeutics Inc
NASDAQ:ANTX
Watchlist
Price: 1.18 USD 3.51%
Market Cap: 32.2m USD

Intrinsic Value

The intrinsic value of one ANTX stock under the Base Case scenario is 3.24 USD. Compared to the current market price of 1.18 USD, AN2 Therapeutics Inc is Undervalued by 64%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ANTX Intrinsic Value
3.24 USD
Undervaluation 64%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
AN2 Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ANTX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ANTX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for AN2 Therapeutics Inc.

Explain Valuation
Compare ANTX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ANTX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
AN2 Therapeutics Inc

Current Assets 67.5m
Cash & Short-Term Investments 62.9m
Other Current Assets 4.6m
Non-Current Assets 8.3m
Long-Term Investments 8.3m
Efficiency

Free Cash Flow Analysis
AN2 Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
AN2 Therapeutics Inc

Revenue
0 USD
Operating Expenses
-41.4m USD
Operating Income
-41.4m USD
Other Expenses
4m USD
Net Income
-37.4m USD
Fundamental Scores

ANTX Profitability Score
Profitability Due Diligence

AN2 Therapeutics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
26/100
Profitability
Score

AN2 Therapeutics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

ANTX Solvency Score
Solvency Due Diligence

AN2 Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

AN2 Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ANTX Price Targets Summary
AN2 Therapeutics Inc

Wall Street analysts forecast ANTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANTX is 1.53 USD with a low forecast of 1.01 USD and a high forecast of 2.1 USD.

Lowest
Price Target
1.01 USD
14% Downside
Average
Price Target
1.53 USD
30% Upside
Highest
Price Target
2.1 USD
78% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

AN2 Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ANTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ANTX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ANTX stock?

The intrinsic value of one ANTX stock under the Base Case scenario is 3.24 USD.

Is ANTX stock undervalued or overvalued?

Compared to the current market price of 1.18 USD, AN2 Therapeutics Inc is Undervalued by 64%.

Back to Top